A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

NCT06524414 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

605

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Disease

Interventions

BIOLOGICAL: PG4
BIOLOGICAL: 20-valent pneumococcal conjugate vaccine (20vPnC)
BIOLOGICAL: 15-valent pneumococcal conjugate vaccine (PCV15)

Sponsor

Pfizer